Release Date: 10/03/11 09:05 Summary: JORC Compliance for Mar 2011 Corporate Presentation Price Sensitive: No Download Document 30.4KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%